Locoregional recurrence after VATS surgery for NSCLC.

about

Locoregional recurrence after VATS surgery for NSCLC.

Item

http://www.wikidata.org/entity/Q42331433

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Locoregional recurrence after VATS surgery for NSCLC.

@en

Locoregional recurrence after VATS surgery for NSCLC.

@nl

type

Item

label

Locoregional recurrence after VATS surgery for NSCLC.

@en

Locoregional recurrence after VATS surgery for NSCLC.

@nl

prefLabel

Locoregional recurrence after VATS surgery for NSCLC.

@en

Locoregional recurrence after VATS surgery for NSCLC.

@nl

P1476

Locoregional recurrence after VATS surgery for NSCLC

@en

P2093

Pierre-Emmanuel Falcoz

http://www.w3.org/2001/XMLSchema#string

P2860

Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study

Patterns of recurrence and incidence of second primary tumors after lobectomy by means of video-assisted thoracoscopic surgery (VATS) versus thoracotomy for lung cancer.

Risk factors for locoregional recurrence in patients with resected N1 non-small cell lung cancer: a retrospective study to identify patterns of failure and implications for adjuvant radiotherapy.

Locoregional control of thoracoscopic lobectomy with selective lymphadenectomy for lung cancer.

Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?

Is video-assisted thoracic surgery lobectomy better than thoracotomy for early-stage non-small-cell lung cancer? A systematic review and meta-analysis.

Long-term survival after lobectomy for non-small cell lung cancer by video-assisted thoracic surgery versus thoracotomy.

Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study.

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial.

From anatomy to lung cancer: questioning lobe-specific mediastinal lymphadenectomy reliability.

P304

E1694-E1696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/JTD.2016.12.54

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gilbert Massard

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28149616

http://www.w3.org/2001/XMLSchema#string

P932

5227236

http://www.w3.org/2001/XMLSchema#string